Le français est une traduction alpha automatisée. Pour le texte officiel, consultez la version anglaise.
Comparer
Comparer à la page en direct
Capture archivée
Provincial and Territorial Routine Vaccination Programs for Healthy, Previously Immunized Adults - Canada.ca
2025-04-18T14:19:55.115Z · legacy-hc-2025-04-21
ID 164868
URL originale ↗Page en direct
Chargement en direct
2026-02-01T08:39:53.816Z
Statut: 200 · Type: text/html;charset=utf-8 · Octets: 45011
URL finale
https://www.canada.ca/en/public-health/services/immunization-vaccines/routine-vaccination-healthy-previously-immunized-adult.html?wbdisable=true(Redirection depuis https://www.canada.ca/en/public-health/services/provincial-territorial-immunization-information/routine-vaccination-healthy-previously-immunized-adult.html?wbdisable=true)
Archive indépendante · Changements descriptifs seulement; la page en direct n’est pas archivée. Citez plutôt la capture (/cite).
8 sections changed; 1 addedContenu principalVariation: 31%+127 / -72 lignes8 sections modifiées
Provincial and territorial routine vaccination programs for healthy, previously immunized adults
Last updated: January 2025
Last updated: December 2025
Download PDF of all vaccine schedules combined (221 KB, 2 pages)
Download PDF of all vaccine schedules combined (228 KB, 2 pages)
On this page
Summary
Provincial and territorial schedules for each vaccine
Summary
These tables summarize the current routine vaccination schedules for healthy, previously immunized adults across Canada grouped by vaccines containing the same antigen and organized alphabetically. These schedules are updated regularly in collaboration with the Canadian Nursing Coalition for Immunization (CNCI) and the Canadian Immunization Committee (CIC).
These tables summarize the current routine vaccination schedules for healthy, previously immunized adults across Canada grouped by vaccines containing the same antigen and organized alphabetically. These schedules are updated regularly in collaboration with the Canadian Immunization Committee (CIC).
Learn more about:
Vaccine recommendations for specific adult populations, such as people who are immunocompromised, published by the
National Advisory Committee on Immunization
Vaccines, vaccine safety, and recommended immunization schedules published in the
Canadian Immunization Guide
and on
Canada.ca
Provincial and territorial schedules for each vaccine
Human papillomavirus vaccines
Human papillomavirus vaccines
Province or territory
HPV
British Columbia
Less than 19 years and some adults less than 27 years
Less than 27 years and some adults aged 27-45 years
Footnote
1
Footnote
3
Alberta
Less than 27 years
Saskatchewan
N/A
Less than 27 years
Manitoba
Footnote
2
N/A
Ontario
N/A
Quebec
Less than 21 years
New Brunswick
Less than 27 years
Nova Scotia
Catch-up program: less than 19 years
Prince Edward Island
18-26 years and adults with risk factors
Footnote
3
Newfoundland and Labrador
N/A
Yukon
Less than 27 years and high-risk individuals up to 45 years
Less than 27 years and high-risk individuals
Northwest Territories
Less than 27 years
Less than 27 years and high-risk individuals
Nunavut
Less than 27 years
Less than 27 years and high-risk individuals aged 28 years and older
Footnotes
Footnote 1
In BC, some people 27 years and older are eligible for the HPV vaccine free of charge, such as those with a chronic illness or weakened immune systems.
Return to footnote
1
referrer
Footnote 2
Manitoba applies the following policy to any publicly funded vaccines: "Once eligible always eligible," so individuals who do not receive a publicly funded vaccine when it is first recommended are eligible to receive the vaccine any time later (unless otherwise stated).
Return to footnote
2
referrer
Footnote 3
In PEI, HPV vaccine is publicly funded for adults with risk factors placing them at increased risk of HPV infection.
HPV vaccine is publicly funded for adults with risk factors placing them at increased risk of HPV infection.
Return to footnote
3
referrer
Definitions
N/A
Vaccine is not publicly funded in the province or territory.
HPV
Human papillomavirus vaccines
Learn more about:
Human papillomavirus (HPV) vaccines
Influenza
Influenza
Province or territory
Inf
British Columbia
Annually for all adults
Alberta
Annually for all adults
Saskatchewan
Annually for all adults
Manitoba
Footnote
1
Annually for all adults
Ontario
Annually for all adults
Quebec
Annually for all adults aged 75+ years
Annually for all adults aged 65+ years
Footnote
2
New Brunswick
Annually for all adults
Nova Scotia
Annually for all adults
Prince Edward Island
Annually for all adults
Newfoundland and Labrador
Annually for all adults
Yukon
Annually for all adults
Northwest Territories
Annually for all adults
Nunavut
Annually for all adults
Footnotes
Footnote 1
Manitoba applies the following policy to any publicly funded vaccines: "Once eligible always eligible," so individuals who do not receive a publicly funded vaccine when it is first recommended are eligible to receive the vaccine any time later (unless otherwise stated).
Return to footnote
1
referrer
Footnote 2
The influenza vaccine is no longer recommended for healthy adults aged 60 to 74 years. For the 2023 to 2024 season, even if the recommendations remain unchanged, the vaccine is offered free of charge for people aged 6 months and over.
The influenza vaccine is offered free of charge on request for people aged 6 months and over.
Return to footnote
2
referrer
Definitions
Inf
Influenza vaccines
Learn more about:
Influenza vaccines
Pneumococcal vaccine
Pneumococcal vaccine
Province or territory
Pneu-P-23
Pneu-C-21
Pneu-C-20
British Columbia
65 years and older, one dose
N/A
65 years and older who have never previously received a dose of Pneu-P-23, Pneu-C-20 or Pneu-C-21 vaccine
Alberta
N/A
65 years and older who have never previously received a dose of Pneu-P-23 vaccine, one dose
65 years and older and high-risk individuals
Saskatchewan
65 years and older who have never previously received a dose of any pneumococcal vaccines
N/A
65 years and older who have never previously received a dose of Pneu-P-23 vaccine, one dose
Manitoba
Footnote
1
N/A
65 years and older who have never previously received a dose of Pneu-P-23 vaccine, one dose
65 years and older who have never previously received a dose of Pneu-P-23 vaccine
Ontario
N/A
65 years and older who have never previously received a dose of Pneu-P-23 vaccine, one dose
65 years and older who have never previously received a dose of Pneu-P-23 vaccine
Quebec
65 years and older, one dose
65 years and older who have not received a Pneu-P-23 vaccine at or after age 65, or a Pneu-C-20 or Pneu-C-21 vaccine at any age
N/A
New Brunswick
N/A
65 years and older who have never previously received a dose of Pneu-P-23 vaccine, one dose
65 years and older who have never previously received a dose of Pneu-P-23 vaccine
Nova Scotia
N/A
65 years and older who have never previously received a dose of Pneu-P-23 vaccine, one dose
65 years and older who have never previously received a dose of Pneu-P-23 vaccine
Prince Edward Island
N/A
65 years and older and high risk individuals, one dose
65 years and older and high risk individuals
Newfoundland and Labrador
N/A
65 years and older and high-risk adults 18 years of age and older, one dose
65 years and older and high risk individuals
Yukon
N/A
65 years and older and high risk individuals, one dose
65 years and older and high risk individuals
Northwest Territories
N/A
65 years and older and high risk individuals, one dose
65 years and older and high risk individuals
Nunavut
50 years and older, one dose
N/A
50 years and older
Footnotes
Footnote 1
Manitoba applies the following policy to any publicly funded vaccines: "Once eligible always eligible," so individuals who do not receive a publicly funded vaccine when it is first recommended are eligible to receive the vaccine any time later (unless otherwise stated).
Return to footnote
1
referrer
Definitions
N/A
Vaccine is not publicly funded in the province or territory.
Pneu-C-20
Pneumococcal conjugate, 20-valent vaccine
Pneu-P-23
Pneu-C-21
Pneumococcal polysaccharide 23-valent vaccine
Pneumococcal conjugate, 21-valent vaccine
Learn more about:
Pneumococcal vaccines
Tetanus, diphtheria and pertussis vaccines
Tetanus, diphtheria and pertussis vaccines
Province or territory
Td
Tdap
British Columbia
Every 10 years
With each pregnancy
Alberta
N/A
Every 10 years and each pregnancy
Saskatchewan
N/A
Every 10 years and each pregnancy
Manitoba
Footnote
1
Every 10 years
N/A
One booster dose per adult lifetime and each pregnancy
Every 10 years and each pregnancy
Ontario
Every 10 years
One booster dose per adult lifetime and each pregnancy
Quebec
One dose at 50 years of age
With each pregnancy
New Brunswick
Every 10 years
One booster dose per adult lifetime and each pregnancy
Nova Scotia
Every 10 years
One booster dose per adult lifetime and each pregnancy
Prince Edward Island
N/A
Every 10 years and each pregnancy
Newfoundland and Labrador
N/A
Every 10 years and each pregnancy
Yukon
Every 10 years
One booster dose per adult lifetime and each pregnancy
Northwest Territories
N/A
Every 10 years and each pregnancy
Nunavut
Every 10 years
One booster dose per adult lifetime and each pregnancy
Footnotes
Footnote 1
Manitoba applies the following policy to any publicly funded vaccines: "Once eligible always eligible," so individuals who do not receive a publicly funded vaccine when it is first recommended are eligible to receive the vaccine any time later (unless otherwise stated).
Return to footnote
1
referrer
Definitions
N/A
Vaccine is not publicly funded in the province or territory
Vaccine is not publicly funded in the province or territory.
Td
Tetanus and diphtheria (reduced toxoid) vaccine
Tdap
Tetanus, diphtheria (reduced toxoid), acellular pertussis (reduced toxoid) vaccine
Learn more about:
Diphtheria toxoid-containing vaccine
Pertussis (whooping cough) vaccines
Tetanus toxoid-containing vaccine
Herpes zoster (shingles) vaccine
Herpes zoster (shingles) vaccine
Province or territory
Zos
British Columbia
N/A
Alberta
N/A
Saskatchewan
N/A
Manitoba
Footnote
1
N/A
Ontario
65 to 70 years of age, two doses
Quebec
75+ years, two doses
75 years and older, two doses
New Brunswick
N/A
Nova Scotia
N/A
Prince Edward Island
50+ years, two doses
50 years and older, two doses
Newfoundland and Labrador
N/A
50 years and older and those aged 18-49 with immunocompromising conditions
Yukon
65 to 79 years of age, two doses
Northwest Territories
N/A
Nunavut
N/A
Footnotes
Footnote 1
Manitoba applies the following policy to any publicly funded vaccines: "Once eligible always eligible," so individuals who do not receive a publicly funded vaccine when it is first recommended are eligible to receive the vaccine any time later (unless otherwise stated).
Return to footnote
1
referrer
Definitions
N/A
Vaccine is not publicly funded in the province or territory.
Zos
Herpes zoster (shingles) vaccine
Learn more about:
Herpes zoster vaccine
Respiratory syncytial virus (RSV) vaccine
Respiratory syncytial virus (RSV) vaccine
Province or territory
RSV
British Columbia
N/A
Alberta
70 years and older, and First Nations, Metis and Inuit individuals aged 60 years and older
Saskatchewan
N/A
Manitoba
60 years and older
Footnote
1
Ontario
Pregnant persons at 32-36 weeks' gestation with delivery expected during RSV season
75 years and older
60 years and older at high-risk
Footnote
2
Quebec
N/A
New Brunswick
75 years and older
Nova Scotia
N/A
Prince Edward Island
75 years and older
Newfoundland and Labrador
60 years and older living in senior congregate living facilities
Yukon
75 years and older
Northwest Territories
N/A
Nunavut
65 years and older
Footnotes
Footnote 1
Eligibility applies to those aged 60 years and older who reside in a personal care home (PCH), have been admitted to a PCH for respite care, or have been admitted to a transitional or chronic care unit while paneled for PCH (including those awaiting placement in a PCH).
Return to footnote
1
referrer
Footnote 2
High-risk criteria for RSV eligibility among individuals aged 60 years and older include being a resident of a long-term care home, Elder Care Lodge, or retirement home, including similar settings such as co-located facilities; being a hospital patient receiving alternate level of care (ALC), including comparable settings such as complex continuing care or hospital transitional programs; having glomerulonephritis (GN) with moderate to severe immunocompromise; receiving hemodialysis or peritoneal dialysis; being a recipient of a solid organ or hematopoietic stem cell transplant; experiencing homelessness; or identifying as First Nations, Inuit, or Métis.
Return to footnote
2
referrer
Definitions
N/A
Vaccine is not publicly funded in the province or territory.
RSV
Respiratory syncytial virus
Learn more about:
RSV vaccines
Page details
Date modified:
2026-01-23
2025-04-03